CV
CapsoVision Inc (CV)
Healthcare • NASDAQ • $7.12-0.97%
- Symbol
- CV
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $7.12
- Daily Change
- -0.97%
- Market Cap
- $354.93M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $15.37
- 52W Low
- $3.43
- Analyst Target
- $10.00
- Dividend Yield
- N/A
- Beta
- N/A
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well…
Company websiteResearch CV on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.